You are here: Home » Companies » News
Business Standard

Alembic Pharma receives US FDA approval for hypertension medicine

The company currently has a total of 82 ANDA approvals from USFDA

Press Trust of India  |  New Delhi 

drugs
Photo: Shutterstock

Drug firm on Wednesday said it has received approval from the US health regulator for Candesartan Cilexetil tablets, used for treatment of hypertension.

The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated (ANDA) Candesartan Cilexetil tablets USP in the strengths of 4 mg, 8 mg, and 16 mg, said in a filing to BSE.

The approved product is therapeutically equivalent to the reference listed drug product (RLD), Atacand tablets of ANI Pharmaceuticals.

Quoting to IQVIA data, said Candesartan Cilexetil tablets have an estimated market size of $22 million for twelve months ending December 2017.

The company currently has a total of 82 ANDA approvals from USFDA, it added.

Shares of were trading 1.33 per cent higher at Rs 623.25 apiece on BSE.

First Published: Wed, December 05 2018. 11:55 IST
RECOMMENDED FOR YOU